Antimicrobial resistance of Pseudomonas aeruginosa biofilms

Microbes and Infection

Volumn 5, Issue 13, 2003, Pages 1213-1219

  Drenkard, Eliana ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antimicrobial resistance; Biofilms; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIINFECTIVE AGENT; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; OFLOXACIN; OXYGEN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; BACTERIOPHAGE; BIOFILM; DNA MICROARRAY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG PENETRATION; DRUG SENSITIVITY; EUKARYOTE; GENOME ANALYSIS; GRAM NEGATIVE BACTERIUM; MICROBIAL METABOLISM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUTRIENT; PHENOTYPE; PLANKTON; PRIORITY JOURNAL; PROKARYOSIS; PROTEIN ANALYSIS; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STRESS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0242569490     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2003.08.009     Document Type: Short Survey

References (51)

1. Nickel J.C., Ruseska I., Wright J.B., Costerton J.W. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob. Agents Chemother. 27:1985;619-624.
2. Shigeta M., Tanaka G., Komatsuzawa H., Sugai M., Suginaka H., Usui T. Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. Chemotherapy. 43:1997;340-345.
3. Suci P.A., Mittelman M.W., Yu F.P., Geesey G.G. Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 38:1994;2125-2133.
4. Vrany J.D., Stewart P.S., Suci P.A. Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa biofilms displaying rapid-transport characteristics. Antimicrob. Agents Chemother. 41:1997;1352-1358.
5. De Beer D., Srinivasan R., Stewart P.S. Direct measurement of chlorine penetration into biofilms during disinfection. Appl. Environ. Microbiol. 60:1994;4339-4344.
6. Huang C.T., Yu F.P., McFeters G.A., Stewart P.S. Nonuniform spatial patterns of respiratory activity within biofilms during disinfection. Appl. Environ. Microbiol. 61:1995;2252-2256.
7. Darouiche R.O., Dhir A., Miller A.J., Landon G.C., Raad I.I., Musher D.M. Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J. Infect. Dis. 170:1994;720-723.
8. Anderl J.N., Franklin M.J., Stewart P.S. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 44:2000;1818-1824.
9. Stone G., Wood P., Dixon L., Keyhan M., Matin A. Tetracycline rapidly reaches all the constituent cells of uropathogenic Escherichia coli biofilms. Antimicrob. Agents Chemother. 46:2002;2458-2461.
10. Walters M.C. III, Roe F., Bugnicourt A., Franklin M.J., Stewart P.S. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47:2003;317-323.
11. Stewart P.S. Mechanisms of antibiotic resistance in bacterial biofilms. Int. J. Med. Microbiol. 292:2002;107-113.
12. Gilbert P., Allison D.G., McBain A.J. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance? Symp. Ser. Soc. Appl. Microbiol. 92:2002;98S-110S.
13. Gilbert P., Maira-Litran T., McBain A.J., Rickard A.H., Whyte F.W. The physiology and collective recalcitrance of microbial biofilm communities. Adv. Microb. Physiol. 46:2002;202-256.
14. Lewis K. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45:2001;999-1007.
15. Xu K.D., Stewart P.S., Xia F., Huang C.T., McFeters G.A. Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl. Environ. Microbiol. 64:1998;4035-4039.
16. Wentland E.J., Stewart P.S., Huang C.T., McFeters G.A. Spatial variations in growth rate within Klebsiella pneumoniae colonies and biofilm. Biotechnol. Prog. 12:1996;316-321.
17. Sternberg C., Christensen B.B., Johansen T., Toftgaard Nielsen A., Andersen J.B., Givskov M., Molin S. Distribution of bacterial growth activity in flow-chamber biofilms. Appl. Environ. Microbiol. 65:1999;4108-4117.
18. Tanaka G., Shigeta M., Komatsuzawa H., Sugai M., Suginaka H., Usui T. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents: beta-lactams and fluoroquinolones. Chemotherapy. 45:1999;28-36.
19. Brooun A., Liu S., Lewis K. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 44:2000;640-646.
20. Evans D.J., Allison D.G., Brown M.R., Gilbert P. Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate. J. Antimicrob. Chemother. 27:1991;177-184.
21. Zabinski R.A., Walker K.J., Larsson A.J., Moody J.A., Kaatz G.W., Rotschafer J.C. Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones. Antimicrob. Agents Chemother. 39:1995;507-512.
22. Tack K.J., Sabath L.D. Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin. Chemotherapy. 31:1985;204-210.
23. Sauer K., Camper A.K., Ehrlich G.D., Costerton J.W., Davies D.G. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J. Bacteriol. 184:2002;1140-1154.
24. Yoon S.S., Hennigan R.F., Hilliard G.M., Ochsner U.A., Parvatiyar K., Kamani M.C., Allen H.L., DeKievit T.R., Gardner P.R., Schwab U., Rowe J.J., Iglewski B.H., McDermott T.R., Mason R.P., Wozniak D.J., Hancock R.E., Parsek M.R., Noah T.L., Boucher R.C., Hassett D.J. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell. 3:2002;593-603.
25. Davies D.G., Geesey G.G. Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl. Environ. Microbiol. 61:1995;860-867.
26. Garrett E.S., Perlegas D., Wozniak D.J. Negative control of flagellum synthesis in Pseudomonas aeruginosa is modulated by the alternative sigma factor AlgT (AlgU). J. Bacteriol. 181:1999;7401-7404.
27. Sauer K., Camper A.K. Characterization of phenotypic changes in Pseudomonas putida in response to surface-associated growth. J. Bacteriol. 183:2001;6579-6589.
28. Whiteley M., Bangera M.G., Bumgarner R.E., Parsek M.R., Teitzel G.M., Lory S., Greenberg E.P. Gene expression in Pseudomonas aeruginosa biofilms. Nature. 413:2001;860-864.
29. Spoering A.L., Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183:2001;6746-6751.
30. Lewis K. Programmed death in bacteria. Microbiol. Mol. Biol. Rev. 64:2000;503-514.
31. Drenkard E., Ausubel F.M. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature. 416:2002;740-743.
32. Massey R.C., Buckling A., Peacock S.J. Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr. Biol. 11:2001;1810-1814.
33. Anriany Y.A., Weiner R.M., Johnson J.A., De Rezende C.E., Joseph S.W. Salmonella enterica serovar Typhimurium DT104 displays a rugose phenotype. Appl. Environ. Microbiol. 67:2001;4048-4056.
34. Wai S.N., Mizunoe Y., Takade A., Kawabata S.I., Yoshida S.I. Vibrio cholerae O1 strain TSI-4 produces the exopolysaccharide materials that determine colony morphology, stress resistance, and biofilm formation. Appl. Environ. Microbiol. 64:1998;3648-3655.
35. Yildiz F.H., Schoolnik G.K. Vibrio cholerae O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation. Proc. Natl. Acad. Sci. USA. 96:1999;4028-4033.
36. Rumbaugh K.P., Griswold J.A., Hamood A.N. The role of quorum sensing in the in vivo virulence of Pseudomonas aeruginosa. Microb. Infect. 2:2000;1721-1731.
37. Pesci E.C., Iglewski B.H. The chain of command in Pseudomonas quorum sensing. Trends Microbiol. 5:1997;132-134.
38. Davies D.G., Parsek M.R., Pearson J.P., Iglewski B.H., Costerton J.W., Greenberg E.P. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 280:1998;295-298.
39. Hassett D.J., Ma J.F., Elkins J.G., McDermott T.R., Ochsner U.A., West S.E., Huang C.T., Fredericks J., Burnett S., Stewart P.S., McFeters G., Passador L., Iglewski B.H. Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol. Microbiol. 34:1999;1082-1093.
40. Shih P.C., Huang C.T. Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance. J. Antimicrob. Chemother. 49:2002;309-314.
41. Beatson S.A., Whitchurch C.B., Semmler A.B., Mattick J.S. Quorum sensing is not required for twitching motility in Pseudomonas aeruginosa. J. Bacteriol. 184:2002;3598-3604.
42. O'Toole G.A., Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30:1998;295-304.
43. Xu K.D., Franklin M.J., Park C.H., McFeters G.A., Stewart P.S. Gene expression and protein levels of the stationary phase sigma factor, RpoS, in continuously-fed Pseudomonas aeruginosa biofilms. FEMS Microbiol. Lett. 199:2001;67-71.
44. Cochran W.L., Suh S.J., McFeters G.A., Stewart P.S. Role of RpoS and AlgT in Pseudomonas aeruginosa biofilm resistance to hydrogen peroxide and monochloramine. J. Appl. Microbiol. 88:2000;546-553.
45. Ma D., Alberti M., Lynch C., Nikaido H., Hearst J.E. The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol. Microbiol. 19:1996;101-112.
46. Zgurskaya H.I., Nikaido H. Multidrug resistance mechanisms: drug efflux across two membranes. Mol. Microbiol. 37:2000;219-225.
47. Stover C.K., Pham X.Q., Erwin A.L., Mizoguchi S.D., Warrener P., Hickey M.J., Brinkman F.S., Hufnagle W.O., Kowalik D.J., Lagrou M., Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y., Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R., Smith K., Spencer D., Wong G.K., Wu Z., Paulsen I.T., Reizer J., Saier M.H., Hancock R.E., Lory S., Olson M.V. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 406:2000;959-964.
48. Chuanchuen R., Narasaki C.T., Schweizer H.P. The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan. J. Bacteriol. 184:2002;5036-5044.
49. Aendekerk S., Ghysels B., Cornelis P., Baysse C. Characterization of a new efflux pump, MexGHI-OpmD, from Pseudomonas aeruginosa that confers resistance to vanadium. Microbiology. 148:2002;2371-2381.
50. Poole K., Srikumar R. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr. Top. Med. Chem. 1:2001;59-71.
51. De Kievit T.R., Parkins M.D., Gillis R.J., Srikumar R., Ceri H., Poole K., Iglewski B.H., Storey D.G. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 45:2001;1761-1770.